My 3 biggest stock market predictions for March

Predicting the stock market isn’t an easy task. But with some key company updates out in March, here are a few things I think we could see.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

One English pound placed on a graph to represent an economic down turn

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Stock market forecasting is mostly a mug’s game. But a lot of companies that I rate as undervalued will deliver results in March. These three in particular have caught my eye.

Aviva

Insurer Aviva (LSE: AV.) will deliver FY22 results on 9 March. The company should announce a share buyback.

A Q3 update said: “Our dividend guidance remains unchanged and, as previously announced, we anticipate commencing additional returns of capital to shareholders with our 2022 full-year results.”

A return could, alternatively, take the form of a special dividend. And that’s a reasonably common way to deal with erratic earnings in the insurance sector.

But forecasts put the price-to-earnings (P/E) at under nine for 2023. And that surely makes Aviva shares look too cheap for the board to ignore. I expect the buyback to be reasonably substantial.

My prediction? Positive results will fail to lift the Aviva share price appreciably, as there seems to be too much inertia holding back financial sector stocks right now. The price might even fall, and I expect Aviva to remain a cheap buy.

Vistry

We’re due full-year results from Vistry Group (LSE: VTY), the housebuilder formerly known as Bovis Homes, on 22 March. I predict something better than expected.

The Vistry share price has recovered well since October’s depths, gaining 55%. So some confidence is creeping back into the sector since last year’s grim sentiment took its toll.

Yes, mortgage rates are rising. Yes, property prices are falling. And yes, the whole housing market is under pressure. But there are two reasons why I think Vistry could report a better start to 2023 than expected.

One is that there’s still pent-up demand from the Covid years, when buying a new house became a distant dream. And the country still faces a major, chronic, housing shortage.

I might be wrong about 2023. But I still rate housebuilders among the Footsie’s best long-term investments.

Synthomer

I predict further share price weakness for Synthomer (LSE: SYNT) on 28 March when we get full-year results.

The shares have fallen more than 50% since last May. This is essentially due to “reduced demand in Synthomer’s construction and coatings end markets,” as the company said in its December update.

Debt is mounting too, although the company recently confirmed the $262m disposal of its laminates, films and coated fabrics businesses.

What do I expect from the results? I hope for more clarity on the firm’s banking agreements, with some reasonable liquidity. And I think we’ll get it.

I see Synthomer as a potential long-term recovery buy. But I fear further pain first.

Verdict

Please don’t take any of my predictions too seriously, as they’re really just speculation. I also haven’t properly examined the risks of any of these three, which potential investors really should do.

But, I can’t help thinking I’d do well to buy all three of these right now, and hold for the long term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has positions in Aviva Plc. The Motley Fool UK has recommended Synthomer Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »